Nitrogen-containing apigenin analogs: preparation and biological activity

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Flavonoids, like apigenin, are plant-derived compounds with potential therapeutic applications.
• Developing novel analogs of natural products can lead to improved pharmacological properties.
• Nitrogen-containing modifications of flavonoids are an area of interest for drug discovery.

Purpose of the Study:

• To synthesize novel nitrogen-containing apigenin analogs.
• To evaluate the in vitro anticancer, antibacterial, and antioxidant activities of these synthesized compounds.
• To identify lead compounds with enhanced biological activities compared to the parent apigenin.

Main Methods:

• Synthesis of apigenin analogs (4a-j) utilizing Mannich reactions.
• Structural elucidation of synthesized compounds using Nuclear Magnetic Resonance ((1)H-NMR, (13)C-NMR) and Electrospray Ionization Mass Spectrometry (ESI-MS).
• In vitro evaluation of antiproliferative activity against human cancer cell lines (HeLa, HepG2, A549, MCF-7), antioxidant activity (DPPH assay), and antibacterial activity against pathogenic bacteria (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa).

Main Results:

• All synthesized apigenin analogs displayed varying degrees of antiproliferative activity against tested cancer cell lines.
• Compound 4i exhibited the most significant antiproliferative effects (IC50 values ranging from 40 to 223 μg/mL) and potent antioxidant activity (IC50 = 334.8 μg/mL).
• Compounds 4h and 4j demonstrated superior antibacterial activity against Gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis) with low Minimum Inhibitory Concentrations (MIC values of 3.91 and 1.95 μg/mL, respectively).

Conclusions:

• The synthesized nitrogen-containing apigenin analogs possess significant anticancer, antibacterial, and antioxidant properties.
• Compound 4i is a promising candidate for further development as an anticancer and antioxidant agent.
• Analogs 4h and 4j show potential as novel antibacterial agents, particularly against Gram-positive pathogens.